Covered recipient · General Payments record

JOSEPH A DIMEO

Allopathic & Osteopathic Physicians Family Medicine

NPI: 1205848942
CMS profile: 54887
Location: YAKIMA, WA

General Payments · PY2018–2024

$9,572.62

Reported across 540 records
CMS publication 2026-01-23

Latest program year · PY2024

$1,429.34

54 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of payment	Amount	Records
Food and Beverage	$1,311.61	52
Education	$99.99	1
Debt forgiveness	$17.74	1

By paying entity

PY2024 · sorted by reported total

Paying entity	Amount	Records
Acerta Pharma LLC	$391.11	7
ABBVIE INC.	$157.27	7
Boehringer Ingelheim Pharmaceuticals, Inc.	$156.63	5
Astellas Pharma US Inc	$152.54	3
PFIZER INC.	$131.90	11
Bayer HealthCare Pharmaceuticals Inc.	$105.31	6
Lundbeck LLC	$70.56	3
NOVARTIS PHARMACEUTICALS CORPORATION	$39.28	2
Novo Nordisk AS	$39.08	2
GlaxoSmithKline, LLC.	$31.73	1
Exact Sciences Corporation	$30.90	1
Takeda Pharmaceuticals U.S.A., Inc.	$24.62	1
Xeris Pharmaceuticals, Inc.	$24.38	1
Sumitomo Pharma America, Inc.	$23.33	1
ITI, Inc.	$18.37	1
BAXTER HEALTHCARE	$17.74	1
DEXCOM, INC.	$14.59	1

By program year

All program years on this page · sorted by year

Program year	Amount	Records
PY2018	$1,756.16	125
PY2019	$1,705.40	121
PY2020	$1,286.57	74
PY2021	$1,136.50	63
PY2022	$951.73	48
PY2023	$1,306.92	55
PY2024	$1,429.34	54

Payment records · PY2024 (54)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018 2019 2020 2021 2022 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.

Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Record ID	Source
ABBVIE INC.	$29.22	02/07/2024	Food and Beverage	Undisputed	01/23/2026	1103643428	CMS
ABBVIE INC.	$32.06	03/19/2024	Food and Beverage	Undisputed	01/23/2026	1103643430	CMS
ABBVIE INC.	$23.53	04/09/2024	Food and Beverage	Undisputed	01/23/2026	1103643432	CMS
ABBVIE INC.	$30.21	05/09/2024	Food and Beverage	Undisputed	01/23/2026	1103643434	CMS
ABBVIE INC.	$11.19	07/12/2024	Food and Beverage	Undisputed	01/23/2026	1103643436	CMS
ABBVIE INC.	$21.73	08/06/2024	Food and Beverage	Undisputed	01/23/2026	1103643438	CMS
ABBVIE INC.	$9.33	11/26/2024	Food and Beverage	Undisputed	01/23/2026	1103643440	CMS
Astellas Pharma US Inc	$23.60	01/23/2024	Food and Beverage	Undisputed	01/23/2026	1139289730	CMS
Astellas Pharma US Inc	$99.99	01/25/2024	Education	Undisputed	01/23/2026	1139388344	CMS
Astellas Pharma US Inc	$28.95	07/18/2024	Food and Beverage	Undisputed	01/23/2026	1139271220	CMS
AstraZeneca Pharmaceuticals LP	$96.56	01/16/2024	Food and Beverage	Undisputed	01/23/2026	1104583086	CMS
AstraZeneca Pharmaceuticals LP	$105.90	03/14/2024	Food and Beverage	Undisputed	01/23/2026	1104288700	CMS
AstraZeneca Pharmaceuticals LP	$22.57	05/22/2024	Food and Beverage	Undisputed	01/23/2026	1105831001	CMS
AstraZeneca Pharmaceuticals LP	$99.65	07/10/2024	Food and Beverage	Undisputed	01/23/2026	1104524130	CMS
AstraZeneca Pharmaceuticals LP	$25.33	08/10/2024	Food and Beverage	Undisputed	01/23/2026	1104440215	CMS
AstraZeneca Pharmaceuticals LP	$18.31	10/11/2024	Food and Beverage	Undisputed	01/23/2026	1105654788	CMS
AstraZeneca Pharmaceuticals LP	$22.79	11/15/2024	Food and Beverage	Undisputed	01/23/2026	1105696362	CMS
Baxter Healthcare	$17.74	09/03/2024	Debt forgiveness	Undisputed	01/23/2026	1117802505	CMS
Bayer Healthcare Pharmaceuticals Inc.	$20.18	02/13/2024	Food and Beverage	Undisputed	01/23/2026	1086197870	CMS
Bayer Healthcare Pharmaceuticals Inc.	$15.83	06/14/2024	Food and Beverage	Undisputed	01/23/2026	1086214137	CMS
Bayer Healthcare Pharmaceuticals Inc.	$25.72	07/13/2024	Food and Beverage	Undisputed	01/23/2026	1086135733	CMS
Bayer Healthcare Pharmaceuticals Inc.	$14.42	09/05/2024	Food and Beverage	Undisputed	01/23/2026	1086199992	CMS
Bayer Healthcare Pharmaceuticals Inc.	$15.05	10/24/2024	Food and Beverage	Undisputed	01/23/2026	1086190684	CMS
Bayer Healthcare Pharmaceuticals Inc.	$14.11	12/05/2024	Food and Beverage	Undisputed	01/23/2026	1086230710	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$33.84	02/20/2024	Food and Beverage	Undisputed	01/23/2026	1117915959	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$33.08	03/29/2024	Food and Beverage	Undisputed	01/23/2026	1117915957	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$27.74	04/30/2024	Food and Beverage	Undisputed	01/23/2026	1117915951	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$29.84	09/13/2024	Food and Beverage	Undisputed	01/23/2026	1117915953	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$32.13	11/12/2024	Food and Beverage	Undisputed	01/23/2026	1117915955	CMS
Dexcom, Inc.	$14.59	08/23/2024	Food and Beverage	Undisputed	01/23/2026	1153311274	CMS
Exact Sciences Corporation	$30.90	04/23/2024	Food and Beverage	Undisputed	01/23/2026	1114637494	CMS
GlaxoSmithKline, LLC.	$31.73	10/08/2024	Food and Beverage	Undisputed	01/23/2026	1116637544	CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$18.37	05/21/2024	Food and Beverage	Undisputed	01/23/2026	1143217226	CMS
Lundbeck LLC	$16.15	09/10/2024	Food and Beverage	Undisputed	01/23/2026	1145910959	CMS
Lundbeck LLC	$25.09	10/04/2024	Food and Beverage	Undisputed	01/23/2026	1145910961	CMS
Lundbeck LLC	$29.32	12/03/2024	Food and Beverage	Undisputed	01/23/2026	1145910963	CMS
Novartis Pharmaceuticals Corporation	$23.00	02/09/2024	Food and Beverage	Undisputed	01/23/2026	1086936297	CMS
Novartis Pharmaceuticals Corporation	$16.28	05/31/2024	Food and Beverage	Undisputed	01/23/2026	1086936303	CMS
Novo Nordisk Inc	$21.42	03/26/2024	Food and Beverage	Undisputed	01/23/2026	1097143805	CMS
Novo Nordisk Inc	$17.66	07/19/2024	Food and Beverage	Undisputed	01/23/2026	1097323122	CMS
PFIZER INC.	$5.08	02/20/2024	Food and Beverage	Undisputed	01/23/2026	1131260567	CMS
PFIZER INC.	$15.30	04/12/2024	Food and Beverage	Undisputed	01/23/2026	1131360948	CMS
PFIZER INC.	$21.48	04/25/2024	Food and Beverage	Undisputed	01/23/2026	1131378736	CMS
PFIZER INC.	$6.86	05/28/2024	Food and Beverage	Undisputed	01/23/2026	1130918222	CMS
PFIZER INC.	$22.36	07/17/2024	Food and Beverage	Undisputed	01/23/2026	1131777792	CMS
PFIZER INC.	$8.76	08/16/2024	Food and Beverage	Undisputed	01/23/2026	1130943569	CMS
PFIZER INC.	$2.01	09/05/2024	Food and Beverage	Undisputed	01/23/2026	1130966176	CMS
PFIZER INC.	$15.86	09/27/2024	Food and Beverage	Undisputed	01/23/2026	1131964397	CMS
PFIZER INC.	$19.33	10/01/2024	Food and Beverage	Undisputed	01/23/2026	1130885144	CMS
PFIZER INC.	$7.53	10/17/2024	Food and Beverage	Undisputed	01/23/2026	1130979561	CMS
PFIZER INC.	$7.33	11/05/2024	Food and Beverage	Undisputed	01/23/2026	1131179307	CMS
Sumitomo Pharma America, Inc.	$23.33	10/29/2024	Food and Beverage	Undisputed	01/23/2026	1148845683	CMS
Takeda Pharmaceuticals U.S.A., Inc.	$24.62	08/20/2024	Food and Beverage	Undisputed	01/23/2026	1137531655	CMS
Xeris Pharmaceuticals, Inc.	$24.38	05/07/2024	Food and Beverage	Undisputed	01/23/2026	1144600208	CMS

Source & provenance

Dataset: CMS Open Payments — General Payments
Publisher of source data: Centers for Medicare & Medicaid Services
CMS publication date: 2026-01-23
Program years on this page: 2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files: Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.